A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

NCT02159690 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped loss of funding

Conditions

Prostate Cancer
Localized Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: Abiraterone acetate
DRUG: Prednisone
DRUG: Dutasteride
DRUG: Degarelix

Sponsor

Kenneth Pienta, MD

Collaborators

[object Object]